Grown Rogue International Inc.GRIN.CN
Key ratios
Operating cash flow growth
2546.1%TTM
2025
36.5%2024
88.6%2023
185.9%
FCF / Sales
-3.8%TTM
2025
-3.4%2024
-5.5%2023
20.5%2023
2.9%
Net margin
-12.6%TTM
2025
5.3%2024
-60.1%2023
-2.3%2023
17.7%
ROA
0.7%TTM
2025
-0.7%2024
0.1%2023
14.2%
ROE
-11.3%TTM
2025
18.7%2024
-133.7%2023
-6.2%
Revenue growth
36.9%TTM
2025
21.8%2024
22.0%2023
31.5%
Recent news
Grown Rogue Begins Cultivation in Minnesota
Canadian Investment Regulatory Organization Trade Resumption - GRIN
Grown Rogue Closes Initial Transactions to Enter New York with Planned Acquisition of PharmaCann's New York License and Assets
Canadian Investment Regulatory Organization Trading Halt - GRIN
Grown Rogue Reports Second Quarter 2026 Results
Grown Rogue to Report Second Quarter 2026 Financial Results and Host Conference Call; Announces Equity Incentive Grants
Track GRIN.CN in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer